Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

Salati, M; Pifferi, M; Baldessari, C; Bertolini, F; Tomasello, C; Cascinu, S; Barbieri, F

Salati, M; Pifferi, M; Baldessari, C; Bertolini, F; Tomasello, C; Cascinu, S; Barbieri, F.

Affiliation

Salati M; Department of Oncology, Università di Modena e Reggio Emilia, Policlinico di Modena, Modena, Italy.
Pifferi M; Unit of Oncology, Hospital of Sassuolo, Modena, Italy.
Baldessari C; Department of Oncology, Università di Modena e Reggio Emilia, Policlinico di Modena, Modena, Italy.
Bertolini F; Department of Oncology, Università di Modena e Reggio Emilia, Policlinico di Modena, Modena, Italy.
Tomasello C; Department of Oncology, Università di Modena e Reggio Emilia, Policlinico di Modena, Modena, Italy.
Cascinu S; Department of Oncology, Università di Modena e Reggio Emilia, Policlinico di Modena, Modena, Italy.
Barbieri F; Department of Oncology, Università di Modena e Reggio Emilia, Policlinico di Modena, Modena, Italy.

Ann Oncol ; 29(1): 283-284, 2018 01 01.

Article de En | MEDLINE | ID: mdl-29045532

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome de Stevens-Johnson / Carcinome pulmonaire non à petites cellules / Nivolumab / Tumeurs du poumon Limites: Female / Humans / Middle aged Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: Italie Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google